Revenue Totaled $15.7 Million, a 27% Increase from Q1, Marking
the Third Consecutive Quarter of Sequential Revenue
Growth
Announced Strategic Review Plan, Initially
Estimated to Yield Annualized Cost Savings of Over $10 Million USD ($12.5
million CAD)
LAVAL, QC, Nov. 15, 2021 /PRNewswire/ - Neptune Wellness
Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX:
NEPT), a diversified and fully integrated health and wellness
company focused on plant-based, sustainable and purpose-driven
lifestyle brands, today announced its financial and operating
results for the three-month period ended on September 30, 2021.
Fiscal Second Quarter 2022 Financial Highlights (all amounts
in CAD unless otherwise noted):
- Revenue totaled $15.7 million, an
increase of 27% from Q1 and third consecutive quarter of revenue
growth.
- Gross profit loss of $1.8 million
compared to gross profit loss of $4.7
million, an improvement of $2.9
million from the quarter ended September 30, 2020.
- Gross margin of (9.5%), a 880 basis point improvement from
(18.3%) in the prior comparable period.
- Net loss of $14.0 million
compared to $22.0 million for the
quarter ended September 30, 2020, an
improvement of $8.0 million.
- Adjusted EBITDA loss improved $3.5
million or 27% for the quarter ended September 30, 2021 to an adjusted EBITDA loss of
$9.5 million compared to $13.0 million for the quarter ended September 30, 2020.
"We are pleased to have delivered 27% revenue growth this
quarter from Q1, our third consecutive quarter of revenue growth,
primarily driven by strong demand for our cannabis flower products,
continued expansion of our Sprout brand into North American
retailers and record sales for Biodroga. During the quarter, we
more than doubled our market penetration for our Canadian cannabis
products to over 1,000 stores where we sell our Mood Ring and
PanHash brands," said Michael
Cammarata, President and Chief Executive Officer of Neptune
Wellness. "We had a record revenue quarter for Biodroga, with sales
driven largely by the continued broad demand for our existing
turnkey solutions, as well as recent innovations."
Fiscal Second Quarter 2022 Business Highlights
- Appointed Randy Weaver as
Interim Chief Financial Officer and John
Wirt as General Counsel.
- Launched Mood Ring™ flower product line in Alberta.
- Launched Sprout® products across Metro Inc. grocery stores in
Canada and further expanded into
new retail chains throughout the region.
Subsequent Events and Business Updates
- Neptune granted U.S. Patent for its unique organic solvent
cannabis extraction process.
- Neptune's subsidiary, Biodroga Nutraceuticals, launched a new
website and showcased its innovative vitamin pumps and sprays at
the 2021 SupplySide West Conference.
- Neptune announced the launch of Mood RingTM branded
vape products in the provinces of Ontario, Alberta and British
Columbia in November.
- The Company appointed KPMG LLP as its new independent
registered public accounting firm, replacing Ernst & Young
LLP.
Strategic Review Results
In the first quarter of fiscal year 2022, Neptune formed a
Strategic Review Committee to evaluate the Company's business plan,
capital deployment, and long-term strategy to identify
opportunities to enhance shareholder value. As a result, Neptune
has developed a comprehensive action plan to generate immediate and
recurring cost savings and focus its efforts towards high-growth
projects. We believe the following initiatives will deliver cost
savings of over $12.5 million CAD per
year and structure Neptune for profitable growth:
- Reallocation of resources towards high-growth and profit areas:
Sprout Foods, Biodroga and cannabis.
- Elimination of non-core operations, including immediate
personnel reductions and a temporary hiring freeze on non-essential
positions.
- Continued commitment to building a culture of improved
transparency and accountability.
Mr. Cammarata continued, "Our Strategic Review Committee, Board
of Directors and management team have carefully outlined key
strategic initiatives to not only continue us on a path of growth,
but more importantly a path to profitability. As a result, we will
refocus our efforts and resources on our key growth drivers,
Sprout, Biodroga, and cannabis. At the same time, we will improve
the efficiency of business units through better supply chain
agreements, personnel reductions and redistribution of resources
previously spent on other pipeline projects. The end result, we
estimate, is initial cost savings of approximately $10 million USD ($12.5
million CAD) annually, which is not expected to slow
growth."
Conference Call Details
Neptune will host a conference call with management today at
5:00 PM EST. The call will be webcast
and can be accessed at www.investors.neptunewellness.com. To listen
to the live call, please go to the website at least 15 minutes
early to register, download and install any necessary audio
software. The webcast will be archived for approximately 90
days.
The unaudited condensed consolidated interim financial
statements of Neptune Wellness Solutions Inc., which were prepared
in accordance with IAS 34, Interim Financial Reporting of
International Financial Reporting Standards ("IFRS"), on a basis
consistent with those accounting policies followed by the
Corporation in the most recent audited consolidated annual
financial statements, and the management discussion and analysis
report for the three-month period ended on September 30, 2021 have been filed on SEDAR at
www.sedar.com and on EDGAR at www.sec.gov/edgar.shtml, and may
also be found on our investor relations website at
www.investors.neptunewellness.com. All amounts are in Canadian
dollars except if specified otherwise.
Non-IFRS Measures
This news release contains a non-IFRS measure, specifically
Adjusted EBITDA. We use Adjusted EBITDA to provide investors with a
supplemental measure of our operating performance and thus
highlight trends in our core business that may not otherwise be
apparent when relying solely on IFRS financial measures. We
believe that securities analysts, investors and other interested
parties frequently use non-IFRS measures in the evaluation of
issuers. Management also uses this non-IFRS measure in order to
facilitate operating performance comparisons from period to period,
prepare annual operating budgets and assess our ability to meet our
capital expenditure and working capital requirements. Adjusted
EBITDA is not recognized, defined or standardized measures under
IFRS. Our definition of Adjusted EBITDA will likely differ from
that used by other companies (including our peers) and therefore
comparability may be limited. Non-IFRS measures should not be
considered a substitute for or in isolation from measures prepared
in accordance with IFRS. Investors are encouraged to review our
financial statements and disclosures in their entirety and are
cautioned not to put undue reliance on non-IFRS measures and view
them in conjunction with the most comparable IFRS financial
measures. For more information on our Adjusted EBITDA, please refer
to our Management Discussion and Analysis for the quarter.
About Neptune Wellness Solutions Inc.
Headquartered in Laval, Quebec,
Neptune is a diversified health and wellness company with a mission
to redefine health and wellness. Neptune is focused on building a
portfolio of high quality, affordable consumer products in response
to long-term secular trends and market demand for natural,
plant-based, sustainable and purpose-driven lifestyle brands. The
Company utilizes a highly flexible, cost-efficient manufacturing
and supply chain infrastructure that can be scaled to quickly adapt
to consumer demand and bring new products to market through its
mass retail partners and e-commerce channels. For additional
information, please visit: https://neptunewellness.com/.
Disclaimer – Safe Harbor Forward–Looking Statements
Forward-looking statements contained in this press release
involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance and achievements of
Neptune Wellness This news release contains "forward-looking
information" and "forward-looking statements" (collectively,
"forward-looking statements") within the meaning of applicable
securities laws. All statements, other than statements of
historical fact, are forward-looking statements and are based on
expectations, estimates, and projections as at the date of this
news release. Any statement that involves discussions with respect
to predictions, expectations, beliefs, plans, projections,
objectives, assumptions, future events or performance (often but
not always using phrases such as "expects", or "does not expect",
"is expected", "anticipates" or "does not anticipate", "plans",
"budget", "scheduled", "forecasts", "estimates", "believes" or
"intends" or variations of such words and phrases or stating that
certain actions, events or results "may" or "could", "would",
"might" or "will" be taken to occur or be achieved) are not
statements of historical fact and may be forward-looking
statements. In this news release, forward-looking statements
include, among other things, statements with respect to the
Company's strategic review, expected cost savings, expected
profitable growth, the success of the Company's action plan,
future increased revenues, expectations regarding expenses,
cash needs, cash flow, liquidity and sources of funding,
future expansion plans, initiatives and strategies of the Company,
and the Company's performance, growth initiatives, profitability,
future product launches and plans and gain in market share.
These forward-looking statements are based on assumptions and
estimates of management of the Company at the time such statements
were made. Actual future results may differ materially as
forward-looking statements involve known and unknown risks,
uncertainties, and other factors which may cause the actual
results, performance, or achievements of the Company to materially
differ from any future results, performance, or achievements
expressed or implied by such forward-looking statements. Such
factors, among other things, include: the ability of the Company to
successfully implement its strategic initiative; implications of
the COVID-19 pandemic on the Company's operations; fluctuations in
general macroeconomic conditions; fluctuations in securities
markets; expectations regarding the size of the cannabis markets
where the Company operates; changing consumer habits; the ability
of the Company to successfully achieve its business objectives and
cost cutting plans; plans for expansion; political and social
uncertainties; inability to obtain adequate insurance to cover
risks and hazards; the ability of the Company to obtain financing
on acceptable terms, the adequacy of our capital resources and
liquidity, including but not limited to, availability of sufficient
cash flow to execute our business plan (either within the expected
timeframe or at all); the ability of the Company to obtain
financing on acceptable terms, expectations regarding the
resolution of litigation and other legal and regulatory
proceedings, reviews and investigations; employee relations; and
the presence of laws and regulations that may impose restrictions
in the markets where the Company operates. Although the
forward-looking statements contained in this news release are based
upon what management of the Company believes, or believed at the
time, to be reasonable assumptions, the Company cannot assure
shareholders that actual results will be consistent with such
forward-looking statements, as there may be other factors that
cause results not to be as anticipated, estimated or intended.
Readers should not place undue reliance on the forward-looking
statements and information contained in this news release. The
Company assumes no obligation to update the forward-looking
statements of beliefs, opinions, projections, or other factors,
should they change, except as required by law.
Additional information regarding these and other risks and
uncertainties relating to the Company's business are contained
under the heading "Risk Factors" in the Company's Annual
Information Form, and under the heading "Risk Disclosure" in the
Company's Management's Discussion and Analysis dated July 15, 2021, for the year ended March 31, 2021, and the Company's quarterly
Management's Discussion and Analysis, filed under the Company's
profile on SEDAR at www.sedar.com.
Neither NASDAQ nor the Toronto Stock Exchange accepts
responsibility for the adequacy or accuracy of this
release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neptune-reports-fiscal-second-quarter-2022-financial-results-301424425.html
SOURCE Neptune Wellness Solutions Inc.